CYP2A13 and lung adenocarcinoma: The reduction in lung adenocarcinoma has been associated with CYP2A13*2 genetic polymorphism [74] given by C→T transition, leading to Arg257Cys substitution and reduced activity of CYP2A13 towards NNK.